Varicella and herpes zoster vaccine development: lessons learnedReview Published on 2017-12-012023-05-31 Journal: Expert review of vaccines [Category] 두창, 수두, 홍역, [키워드] herpes zoster Live attenuated vaccine Post-marketing surveillance Subunit vaccine vaccine effectiveness vaccine efficacy vaccine safety. varicella [DOI] 10.1080/14760584.2017.1394843 PMC 바로가기 [Article Type] Review
Efficacy of Maternal Influenza Vaccination Against All-Cause Lower Respiratory Tract Infection Hospitalizations in Young Infants: Results From a Randomized Controlled Trial영아의 모든 원인 하기도 감염 입원에 대한 산모 인플루엔자 예방 접종의 효능: 무작위 대조 시험의 결과Articles and Commentaries Published on 2017-10-012022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] Against age Analysis Bacterial infection Bacterial infections benefit clinical confidence interval Controlled double-blind during pregnancy Efficacy evaluated Hospitalization hospitalizations Hospitalized immunization inactivated incidence incidence rate infancy Infant Infants Infection Influenza influenza infection influenza vaccination influenza vaccine Influenza virus laboratory-confirmed life Lower Lower respiratory tract lower respiratory tract infection lower respiratory tract infections Maternal median age occurred participated phase 3 trial placebo group placebo recipient placebo recipients placebo-controlled positive Pregnancy pregnant women probe PROTECT randomized clinical trial rate ratio RCT recipient Registration respiratory Result severe pneumonia subsequent tested the placebo group tract trivalent vaccination Vaccine vaccine efficacy virus infection women [DOI] 10.1093/cid/cix497 PMC 바로가기 [Article Type] Articles and Commentaries
Protection of commercial turkeys following inactivated or recombinant H5 vaccine application against the 2015U.S. H5N2 clade 2.3.4.4 highly pathogenic avian influenza virusArticle Published on 2017-09-012023-06-02 Journal: Veterinary Immunology and Immunopathology [Category] 조류인플루엔자, [키워드] Highly pathogenic avian influenza virus recombinant vaccine reverse genetics Turkey (Meleagris gallopavo) vaccine efficacy Viral shedding. [DOI] 10.1016/j.vetimm.2017.08.001 PMC 바로가기
Contribution of Serologic Assays in the Evaluation of Influenza Virus Infection Rates and Vaccine Efficacy in Pregnant Women: Report From Randomized Controlled Trials임산부의 인플루엔자 바이러스 감염률 및 백신 효능 평가에서 혈청학적 분석의 기여: 무작위 대조 시험의 보고서Major Article Published on 2017-06-152022-09-06 Journal: Clinical Infectious Diseases: An Official Publicat [Category] Communicable Disease, [키워드] 95% CI 95% confidence interval Analysis antibody collected Controlled defined diagnosed diagnostic during pregnancy Efficacy episode of evaluate Evidence evidence of exposure to greater hemagglutination inhibition assay. HIV-uninfected Human immunodeficiency virus immunodeficiency virus immunogenicity inactivated incidence increase in Influenza influenza infection influenza vaccine Influenza virus molecular pharyngeal phase III trial placebo recipients polymerase chain polymerase chain reaction Post hoc analysis postvaccination Pregnancy pregnant pregnant women Prevent prevented provided randomized clinical trial Rate report required Seasonal influenza serologic serologic testing Serologically specimen utility vaccination Vaccine vaccine efficacy virus women [DOI] 10.1093/cid/cix241 PMC 바로가기 [Article Type] Major Article
Immunogenicity and Efficacy of A/H1N1pdm Vaccine Among Subjects With Severe Motor and Intellectual Disability in the 2010/11 Influenza SeasonArticle Published on 2016-06-052023-06-08 Journal: Journal of Epidemiology [Category] 신종인플루엔자, [키워드] antibody efficacy disabled person immunogenicity influenza vaccine vaccine efficacy [DOI] 10.2188/jea.JE20150036 PMC 바로가기
Modeling the durability of ZOSTAVAX® vaccine efficacy in people ≥60 years of ageArticle Published on 2015-03-172023-06-01 Journal: Vaccine [Category] 두창, 수두, 홍역, [키워드] Concurrent age effect Durability herpes zoster Poisson regression Time effect vaccine efficacy zoster vaccine. [DOI] 10.1016/j.vaccine.2014.10.039 PMC 바로가기
Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trialHIV-1에 감염된 건강한 성인에서 후보 결핵 백신 MVA85A의 안전성, 면역원성 및 효능: 무작위, 위약 대조, 2상 시험Articles Published on 2015-03-012022-09-06 Journal: The Lancet. Respiratory Medicine [Category] Communicable Disease, [키워드] 1:1 95% CI absence active tuberculosis adverse event Antigen antigen 85A antigen 85A-specific T-cell response antiretroviral Antiretroviral therapy assigned assist baseline baseline CD4 block blocks booster Cape CD4 count CD4 counts Cell clinical defined detect detectable Developing disease double-blind effective Efficacy eligible Eligible participants enrolled enrolment European Evidence evidence of expressing finding first vaccination foundation funding gold greater Group allocation had no healthy HIV-1 HIV-1 infection immunogenic immunogenicity include increased risk Infection injection intradermal injections investigators isoniazid isoniazid prophylaxis Laboratory latent tuberculosis latent tuberculosis infection M tuberculosis Measures Melinda Gate Melinda Gates modified vaccinia virus MVA85A Mycobacterium tuberculosis nine no evidence of Nurses occurred outcome participant partnership peaked per-protocol analysis per-protocol population Phase 2 phase 2 trial Placebo placebo group placebo-controlled positive Potential Prophylaxis protocol QuantiFERON QuantiFERON-TB Gold In-Tube randomisation randomised Randomly receive receiving Registered reported Safe Safety safety analysis second vaccination secondary Secondary outcomes sequence Serious Adverse Event Serious Adverse Events significant increase South Africa stratified subset T-cell Response the placebo group therapy town Treatment Trial Tuberculosis tuberculosis disease tuberculosis vaccine undetectable vaccination Vaccine vaccine efficacy vaccine-induced immune response Viral Viral load Wellcome Trust were assessed [DOI] 10.1016/S2213-2600(15)00037-5 PMC 바로가기 [Article Type] Articles